News

Studies presented at #AHS18SF explore the link between 4 commonly believed migraine triggers and the onset of a migraine attack

Publishing academic manuscripts in peer-reviewed journals is a very competitive process: Most academic journals accept around 20-30% of manuscript submissions, while more competitive journals such as TheNew England Journal of Medicine only accept around 5% of submissions.

Richard Lipton wins the Harold G. Wolff Award for the fifth time and donates winnings to the American Migraine Foundation

Matthew Robbins, MD, FAHS, AHS Board Member and Chair of the Resident Education Program, is an Associate Professor of Neurology at the Albert Einstein College of Medicine and Neurologist at the Montefiore Headache Center in New York.

Clinical Studies at American Headache Society 60th Annual Scientific Meeting Show Impact of Migraine Across Various Stages of Women’s Lives

New AHS President Kathleen Digre shares her experience and advocacy with the organization

AHS doctors discuss the contraindication of contraceptives for women with migraine with aura

Hans-Christoph Diener, MD, PhD expands on stroke risks specific to women with migraine with aura.

Emerging treatments, such as calcitonin gene-related peptide (CGRP)-blocking antibodies, hope to put an end to migraine. Dr. David Dodick explains how and why they work.

New research provides a contemporary estimate of the true cost of migraine

The American Headache Society and Medscape announce collaboration on a new resource for the treatment of migraine

In January, the British Medical journal published an article by Adelborg and colleagues which showed that patients with migraine are more likely to have cardiovascular disease, venous thromboembolism, atrial fibrillation and atrial flutter.

Headache is a common reason that patients seek out medical care. It is the fifth most common reason for emergency department (ED) visits and accounts for more than 10 million physician visits annually.